Immundiagnostik AG of Bensheim at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Immundiagnostik AG

Stubenwald-Allee 8 A, 64625 Bensheim
Telephone +49 6251 701900
Fax +49 6251 849430

Hall map

MEDICA 2018 hall map (Hall 3): stand E59

Fairground map

MEDICA 2018 fairground map: Hall 3


Dr. Karl Wintgens



Our range of products

Product categories

  • 02  Laboratory Technology
  • 02.03  Chromatographs


  • 03  Diagnostic Tests
  • 03.01  Clinical chemistry
  • 03.01.02  Haemoglobin testing, electrophoresis testing

Haemoglobin testing, electrophoresis testing

  • 03  Diagnostic Tests
  • 03.01  Clinical chemistry
  • 03.01.03  Urinalysis equipment and systems

Urinalysis equipment and systems

  • 03  Diagnostic Tests
  • 03.01  Clinical chemistry
  • 03.01.04  Rapid tests in clinical chemistry

Rapid tests in clinical chemistry

  • 03  Diagnostic Tests
  • 03.01  Clinical chemistry
  • 03.01.05  Other equipment for clinical chemistry

Other equipment for clinical chemistry

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.03  Diagnostic tests for cancer

Diagnostic tests for cancer

  • 03  Diagnostic Tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.04  Other molecular diagnostics testing

Other molecular diagnostics testing

  • 03  Diagnostic Tests
  • 03.07  Other diagnostics

Other diagnostics

Our products

Product category: Immuno assay testing

IDK® Zonulin ELISA

Zonulin is a novel human protein analogue to the zonula occludens toxin derived
from Vibrio cholerae which participates in tight junctions between cells of the wall
of the digestive tract. Zonulin binds to a specific receptor on the surface of intestinal
epithelia and triggers a cascade of biochemical events which induces tight junction
disassembly and a subsequent permeability increase of the intestinal epithelia, allowing
some substances to pass through and activate immune reactions.
Fasano and his co-workers found that the zonulin-zonulin-receptor-system is more
activated in celiac disease and type 1 diabetes mellitus patients. Patients with active
celiac disease showed higher levels of zonulin and anti-zonulin antibodies compared
to non-celiac patients and patients in remission, who were on a gluten-free diet.
Concerning the autoimmune type 1 diabetes, in experiments with rats it could be
demonstrated that elevated zonulin levels as well as increased intestinal permeability
precede a type 1 diabetes disease. Conversely, type 1 diabetes could be prevented
by inhibition of zonulin in animal experiments.
In addition, it was reported that many people who suffer from celiac disease also suffer
from other autoimmune disorders. It is suggested that increased levels of zonulin
are a contributing factor to the development of celiac disease and other autoimmune
disorders such as insulin dependent diabetes, multiple sclerosis and rheumatoid

More Less

About us

Company details

Immundiagnostik AG (, founded in 1986 by Dr. Franz Paul Armbruster (CEO), is specialized on the development, production, and world-wide distribution of innovative parameters and detection methods for laboratory diagnostics and medical research. The main focus is the development of immunological tools, of HPLC and molecular biology methods, and of new applications for mass spectrometry (LC-MS/MS). Immundiagnostik concentrates on the development and production of laboratory diagnostics for the identification of disease risks, for differential diagnosis, and for therapeutic drug monitoring. The company holds a particularly strong portfolio in markers of oxidative stress/anti-aging, gastroenterology and nutrition, skeletal system, and cardio-reno-vascular system. Immundiagnostik owns more than 35 patents in Europe, the US, Japan, Canada, and Australia, is certified according to DIN EN ISO 13485 and fulfills the requirements of the German Medical Device Regulation and the EU IVD Regulations (98/79 EG).

More Less

Company data

Sales volume

10-49 Mio US $

Export content

max. 75%

Number of employees




Area of business